Literature DB >> 12825092

Association between A2a receptor gene polymorphisms and caffeine-induced anxiety.

Karen Alsene1, Jürgen Deckert, Philipp Sand, Harriet de Wit.   

Abstract

The adenosine receptor system, which mediates the psychoactive effects of caffeine, is also thought to be involved in the regulation of anxiety. In this study, we examined the association between variations in anxiogenic responses to caffeine and polymorphisms in the A1 and A2a adenosine receptor genes. Healthy, infrequent caffeine users (N=94) recorded their subjective mood states following a 150 mg oral dose of caffeine freebase or placebo in a double-blind study. We found a significant association between self-reported anxiety after caffeine administration and two linked polymorphisms on the A2a receptor gene, the 1976C>T and 2592C>Tins polymorphisms. Individuals with the 1976T/T and the 2592Tins/Tins genotypes reported greater increases in anxiety after caffeine administration than the other genotypic groups. The study shows that an adenosine receptor gene polymorphism that has been associated with Panic Disorder is also associated with anxiogenic responses to an acute dose of caffeine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12825092     DOI: 10.1038/sj.npp.1300232

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  88 in total

1.  Impact of genetic variations in ADORA2A gene on depression and symptoms: a cross-sectional population-based study.

Authors:  Sílvia Oliveira; Ana Paula Ardais; Clarissa Ribeiro Bastos; Marta Gazal; Karen Jansen; Luciano de Mattos Souza; Ricardo Azevedo da Silva; Manuella Pinto Kaster; Diogo Rizzato Lara; Gabriele Ghisleni
Journal:  Purinergic Signal       Date:  2018-12-03       Impact factor: 3.765

Review 2.  Genetics of caffeine consumption and responses to caffeine.

Authors:  Amy Yang; Abraham A Palmer; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2010-06-09       Impact factor: 4.530

Review 3.  A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features.

Authors:  Laura M Juliano; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2004-09-21       Impact factor: 4.530

4.  PharmGKB summary: caffeine pathway.

Authors:  Caroline F Thorn; Eleni Aklillu; Ellen M McDonagh; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2012-05       Impact factor: 2.089

5.  Polymorphisms of ADORA2A modulate psychomotor vigilance and the effects of caffeine on neurobehavioural performance and sleep EEG after sleep deprivation.

Authors:  S Bodenmann; C Hohoff; C Freitag; J Deckert; J V Rétey; V Bachmann; H-P Landolt
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

6.  Individual cyclic variations in the brain Δ rhythm during slow-wave sleep in humans.

Authors:  Yu Yu Sysoeva; E V Verbitsky
Journal:  Dokl Biol Sci       Date:  2012-07-05

7.  Human behavioral pharmacology, past, present, and future: symposium presented at the 50th annual meeting of the Behavioral Pharmacology Society.

Authors:  Sandra D Comer; Warren K Bickel; Richard Yi; Harriet de Wit; Stephen T Higgins; Galen R Wenger; Chris-Ellyn Johanson; Mary Jeanne Kreek
Journal:  Behav Pharmacol       Date:  2010-07       Impact factor: 2.293

8.  Allelic variation in TAS2R bitter receptor genes associates with variation in sensations from and ingestive behaviors toward common bitter beverages in adults.

Authors:  John E Hayes; Margaret R Wallace; Valerie S Knopik; Deborah M Herbstman; Linda M Bartoshuk; Valerie B Duffy
Journal:  Chem Senses       Date:  2010-12-16       Impact factor: 3.160

9.  Affective response to physical activity as an intermediate phenotype.

Authors:  Harold H Lee; Jessica A Emerson; Lauren Connell Bohlen; David M Williams
Journal:  Soc Sci Med       Date:  2018-11-10       Impact factor: 4.634

10.  Effects of caffeine on performance and mood: withdrawal reversal is the most plausible explanation.

Authors:  Jack E James; Peter J Rogers
Journal:  Psychopharmacology (Berl)       Date:  2005-07-02       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.